Nicholas C Richardson - Center for Drug Evaluation and Research, U.S. Food and Drug Administration

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 24 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Development of a Novel Methodology to Assess Response to Lymphoma Treatment in Real-World Data

Andrew J. Klink,Richard Scott Swain,Kristin M. Zimmerman Savill, Bindu Kalesan,Parisa Asgarisabet,Alexandrina Balanean, Harlen Hays,Jill Kaufman,Lindsay McAllister, Hsing-Ting Yu,Jalyna R. Laney,Nicholas C. Richardson,Catherine C. Lerro,Fatima Rizvi,Jonathon Vallejo, Kun Wang,Marc R. Theoret,Donna Rivera,Bruce A. Feinberg

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用0浏览0引用

Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development (vol 13, pg 2515, 2023)

Joshua M. Donaldson, Marjilla Seddiq,Michael J. Fusco, Shyamli Singla,Gulsum E. Pamuk, Rosa J. Lee-Alonso,Bronwyn D. Mixter,Kirsten B. Goldberg,Laleh Amiri-Kordestani,R. Angelo de Claro,Nicole Drezner,Nicole J. Gormley,Bindu Kanapuru,Steven J. Lemery,Lola A. Fashoyin-Aje,Nicholas C. Richardson,Harpreet Singh,Daniel L. Suzman,Marc R. Theoret,Paul G. Kluetz,Richard Pazdur

CANCER DISCOVERYno. 5 (2024): 890-890

引用0浏览0引用

Concordance Between Physician Response Assessment and a Novel Method Per Lugano Criteria in Patients with Lymphoma Using Real-World Data

Richard Scott Swain,Andrew J. Klink,Kristin M. Zimmerman Savill,Parisa Asgarisabet, Bindu Kalesan,Alexandrina Balanean, Harlen Hays,Jill Kaufman,Lindsay McAllister, Hsing-Ting Yu,Jalyna R. Laney,Nicholas C. Richardson,Catherine C. Lerro,Fatima Rizvi,Jonathon Vallejo, Kun Wang,Marc R. Theoret,Donna Rivera,Bruce A. Feinberg

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用0浏览0引用

FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-cell Lymphomas

Maryam Sarraf Yazdy,Yvette L Kasamon, Wenjuan Gu,Lisa R Rodriguez,Susan Jin,Vishal Bhatnagar,Nicholas C Richardson,Marc R Theoret,Richard Pazdur,Nicole J Gormley

Clinical cancer research an official journal of the American Association for Cancer Researchno. 24 (2024): 5521-5526

引用0浏览0WOS引用

Fda accelerated approval: oncology nurse implications with pi3k inhibitors

Natasha Kormanik, Laura Wall, Denise Felluca,Nicholas Richardson,Nicole Gormley,Theresa Carioti

ONCOLOGY NURSING FORUM（2023）

引用0浏览0引用

Data from the Impact of Improved Treatments on Survival of Adult U.S. Leukemia Patients: 1990–2018

Nadia Howlader,Elad Sharon,Manami Bhattacharya,Lori A. Ehrlich,Nicholas C. Richardson,Nicole J. Gormley,R. Angelo de Claro,Amy E. Wood,Angela B. Mariotto,Kathleen A. Cronin

Cancer Epidemiology Biomarkers & Prevention（2023）

引用2浏览0WOS引用

Clinical Development of Pediatric Program within Rare Diseases

Jingjing Ye, Li Ma,Amy Barone,Nicholas Richardson, Emily Wearne, Kerry Jo Lee, Charu Gandotra

Chapman and Hall/CRC eBookspp.117-167, (2023)

引用1浏览0引用

Underrepresentation of Older Adults in Clinical Trials of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hematologic Malignancies: an FDA Analysis

Pamela Seam,Upendra Mahat,Najat Bouchkouj,Poornima Sharma, Helka Peredo-Pinto,Mona Elmacken,Megha Kaushal, Yuxia Jia,Shu Wang, Zhiheng Xu,Yvette Kasamon, Bindu Kanaparu,Nicholas Richardson,Nicole Gormley

BLOOD (2023)

引用0浏览0引用

Underrepresentation of Racial and Ethnic Minorities in Registrational Chimeric Antigen Receptor (CAR) T-Cell Therapy Trials in Hematologic Malignancies: an FDA Analysis

Upendra Mahat,Pamela Seam,Najat Bouchkouj,Poornima Sharma, Helka Peredo-Pinto,Mona Elmacken,Megha Kaushal,Shu Wang, Zhiheng Xu, Yuxia Jia,Nicholas Richardson,Bindu Kanapuru,Yvette Kasamon,Nicole Gormley

BLOOD（2023）

引用0浏览0引用

Supplementary Figure 1 from the Impact of Improved Treatments on Survival of Adult U.S. Leukemia Patients: 1990–2018

Nadia Howlader,Elad Sharon,Manami Bhattacharya,Lori A. Ehrlich,Nicholas C. Richardson,Nicole J. Gormley,R. Angelo de Claro,Amy E. Wood,Angela B. Mariotto,Kathleen A. Cronin

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn